The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday.
Emergent: FDA letting troubled COVID vaccine factory restart
→
Emergent BioSolutions executives said Wednesday they accept full responsibility for spoiling millions of COVID-19 vaccine doses at a Baltimore plant and pledged to fix problems with "diligence" and "urgency" amid the pandemic.
Emergent BioSolutions CEO: We take 'full responsibility' for vaccine mishap
→